Recombinant Human CD59 Protein, ≥95% (SDS-PAGE), high purity

Features and benefits
  • Expression System: HEK293
  • Accession #: P13987
  • Protein Tag: C-10His
  • Bioactivity: When recombinant human C9 is coated at 5 μg/mL (100 μL/well), the concentration of Recombinant Human CD59 that produces 50% optimal binding response is 0.6‑3 μg/mL.
  • Endotoxin Concentration: <0.1 EU/μg
Item Number
rp144061
Grouped product items
SKUSizeAvailabilityPrice Qty
rp144061-10μg
10μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$139.90
rp144061-50μg
50μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$269.90
rp144061-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$439.90
rp144061-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,199.90

Animal Free, ≥95% (SDS-PAGE), Active, 293F, C-10*His tag, 26-102 aa

View related series
Accession#: P13987 CD59 Gene ID: 966

Basic Description

Product NameRecombinant Human CD59 Protein, ≥95% (SDS-PAGE), high purity
GradeActiBioPure™, Animal Free, Azide Free, Bioactive, Carrier Free
Product Description

Purity
≥95% (SDS-PAGE)
Endotoxin level
<0.1 EU/μg

Function
Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes.

Specifications & PurityActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, ≥95%(SDS-PAGE)
Purity≥95% (SDS-PAGE)
BioactivityWhen recombinant human C9 is coated at 5 μg/mL (100 μL/well), the concentration of Recombinant Human CD59 that produces 50% optimal binding response is 0.6‑3 μg/mL.
Endotoxin Concentration<0.1 EU/μg
Expression SystemHEK293
SpeciesHuman
Amino Acids26-102 aa
SequenceLQCYNCPNPTADCKTAVNCSSDFDACLITKAGLQVYNKCWKFEHCNFNDVTTRLRENELTYYCCKKDLCNFNEQLENHHHHHHHHHH
Protein TagC-10His
Accession #P13987
Predicted molecular weight10 kDa
SDS-PAGE11.5 & 15.2 kDa, under reducing conditions; 11.5 & 15.2 kDa, under non-reducing conditions.

Product Specifications

FormLyophilized
ReconstitutionReconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -20~-80℃ for more than 1 year. Upon delivery aliquot. Avoid freeze/thaw cycle.

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Todd D Taylor,Hideki Noguchi,Yasushi Totoki,Atsushi Toyoda,Yoko Kuroki,Ken Dewar,Christine Lloyd,Takehiko Itoh,Tadayuki Takeda,Dae-Won Kim,Xinwei She,Karen F Barlow,Toby Bloom,Elspeth Bruford,Jean L Chang,Christina A Cuomo,Evan Eichler,Michael G FitzGerald,David B Jaffe,Kurt LaButti,Robert Nicol,Hong-Seog Park,Christopher Seaman,Carrie Sougnez,Xiaoping Yang,Andrew R Zimmer,Michael C Zody,Bruce W Birren,Chad Nusbaum,Asao Fujiyama,Masahira Hattori,Jane Rogers,Eric S Lander,Yoshiyuki Sakaki.  (2006-03-24)  Human chromosome 11 DNA sequence and analysis including novel gene identification..  Nature,  440  ((7083)): (497-500).  [PMID:16554811]
2. Ninomiya, H H and Sims, P J PJ..  (1992)  The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9..  The Journal of biological chemistry,    (5):   [PMID:1377690]
3. Petranka, J G JG, Fleenor, D E DE, Sykes, K K, Kaufman, R E RE and Rosse, W F WF..  (1992)  Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein..  Proceedings of the National Academy of Sciences of the United States of America,    (1):   [PMID:1381503]
4. Motoyama, N N, Okada, N N, Yamashina, M M and Okada, H H..  (1992)  Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene..  European journal of immunology,      [PMID:1382994]
5. Tone, M M, Walsh, L A LA and Waldmann, H H..  (1992)  Gene structure of human CD59 and demonstration that discrete mRNAs are generated by alternative polyadenylation..  Journal of molecular biology,    (5):   [PMID:1383553]
6. Philbrick, W M WM and 5 more authors..  (1990)  The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility..  European journal of immunology,      [PMID:1689664]
7. Sawada, R R and 6 more authors..  (1990)  Isolation and expression of the full-length cDNA encoding CD59 antigen of human lymphocytes..  DNA and cell biology,      [PMID:1692709]
8. Okada, H H and 6 more authors..  (1989)  20 KDa homologous restriction factor of complement resembles T cell activating protein..  Biochemical and biophysical research communications,    (15):   [PMID:2475111]
9. Davies, A A and 6 more authors..  (1989)  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells..  The Journal of experimental medicine,    (1):   [PMID:2475570]
10. Sawada, R R and 5 more authors..  (1989)  Complementary DNA sequence and deduced peptide sequence for CD59/MEM-43 antigen, the human homologue of murine lymphocyte antigen Ly-6C..  Nucleic acids research,    (25):   [PMID:2476718]
11. Sugita, Y Y and 9 more authors..  (1989)  Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement..  Journal of biochemistry,      [PMID:2606909]
12. Kieffer, B B and 5 more authors..  (1994)  Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins..  Biochemistry,    (19):   [PMID:7512825]
13. Fletcher, C M CM, Harrison, R A RA, Lachmann, P J PJ and Neuhaus, D D..  (1994)  Structure of a soluble, glycosylated form of the human complement regulatory protein CD59..  Structure (London, England : 1993),    (15):   [PMID:7520819]
14. Sugita, Y Y and 6 more authors..  (1993)  Determination of carboxyl-terminal residue and disulfide bonds of MACIF (CD59), a glycosyl-phosphatidylinositol-anchored membrane protein..  Journal of biochemistry,      [PMID:8276756]
15. Meri, S S, Lehto, T T, Sutton, C W CW, Tyynelä, J J and Baumann, M M..  (1996)  Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis..  The Biochemical journal,    (15):   [PMID:8670172]
16. Bodian, D L DL, Davis, S J SJ, Morgan, B P BP and Rushmere, N K NK..  (1997)  Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59..  The Journal of experimental medicine,    (3):   [PMID:9053451]
17. Rudd, P M PM and 7 more authors..  (1997)  The glycosylation of the complement regulatory protein, human erythrocyte CD59..  The Journal of biological chemistry,    (14):   [PMID:9054419]
18. Yu, J J and 5 more authors..  (1997)  Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity..  Biochemistry,    (5):   [PMID:9235986]
19. Acosta, J J and 6 more authors..  (2000)  Molecular basis for a link between complement and the vascular complications of diabetes..  Proceedings of the National Academy of Sciences of the United States of America,    (9):   [PMID:10805801]
20. Nevo, Yoram Y and 15 more authors..  (2013)  CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy..  Blood,    (3):   [PMID:23149847]

Solution Calculators